Skip to main content
Clinical Trials/IRCT20221207056741N1
IRCT20221207056741N1
Completed
未知

The effect of single and dual task balance training on balance, cognitive function and fear of falling retired recovered from COVID-19

Bagheiat-allah University of Medical Sciences0 sites45 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Bagheiat-allah University of Medical Sciences
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Bagheiat-allah University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Aging between 60\-80
  • Ability to stand for a minute and walk for 10 for 10 minutes without and aids and stick
  • Normal vision
  • Being able to read and write
  • Being healthy or not having used any balance affecting medicine
  • Having tested positive in COVID19 and being hospitalized in a recent year
  • Living in Kerman city
  • Scoring more than 24 points at Standardized Mini\-Mental State Examination

Exclusion Criteria

  • Progressive neurological condition such as Parkinson disease, or Alzheimer
  • Existence of cardiovascular disease (myocardial infarction, congestive heart disease, uncontrolled blood pressure, hypotension, decreased heart rate)
  • Significant visual and auditory impairments
  • History of depression, anxiety or other mental disorders
  • Having a history of rheumatic and metabolic diseases such as rheumatoid arthritis, diabetes
  • Existence of severe deformities of the joints of the lower limbs or trunk, such as severe Kyphosis or scoliosis, severe osteoarthritis of the hip and knee joints.
  • Having a history of balance disorder and frequent positional dizziness
  • Having a history of joint replacement in the lower limb
  • Consuming alcohol, sedatives or any type of special medicine that affects balance or cognitive status.
  • High inflammation of lungs up to 40% due to COVID 19

Outcomes

Primary Outcomes

Not specified

Similar Trials